FOLFOX4 Drug Combo Proven Effective

Preliminary results from a clinical trial indicated that a combination of FOLFOX4 and Avastin helped people with advanced colorectal cancer live longer than FOLFOX4 alone.

In the trial, one group of patients received an Eloxatin regimen known as FOLFOX4. The other group was treated with the FOLFOX4 regimen and Avastin.

Results showed that people treated with the Eloxatin/Avastin combination lived longer.

This helps demonstrate why it's a good idea to consider joining a clinical trial if conventional treatment isn't working. Clinical trial participants generally receive free medical care and have access to experimental treatments. One of the major drawbacks, in my opinion, is that you may be receiving a placebo without knowing it. It's not an easy decision to make.

Related Research:

• Adding Avastin May Add Years to Your Life
  
• FOLFOX4 Plus Avastin: Worth a Try?

Related News:

• FDA Approval of Avastin as a Second-Line Treatment for Colon Cancer
  
• Avastin Approved in EU and Switzerland
  
• Avastin Warning
  
• FDA Approval of Avastin as a Colorectal Cancer Treatment

_{Source: Bevacizumab Combined With Oxaliplatin-Based Chemotherapy Prolongs Survival for Previously Treated Patients With Advanced Colorectal Cancer. NCI News. 24 Aug. 2006 [http://www.nci.nih.gov/newscenter/pressreleases/BevacizumabOxaliplatin].}